Synergetics Usa, Inc. (NASDAQ: SURG) reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15 million.

For earnings history and earnings-related data on Synergetics Usa, Inc. (SURG) click here.

Earnings